10,453 Shares in Medtronic PLC (NYSE:MDT) Acquired by One Wealth Advisors LLC

One Wealth Advisors LLC purchased a new stake in Medtronic PLC (NYSE:MDT - Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 10,453 shares of the medical technology company's stock, valued at approximately $946,000.

Other institutional investors have also added to or reduced their stakes in the company. Innova Wealth Partners purchased a new stake in Medtronic during the 1st quarter valued at about $209,000. Journey Strategic Wealth LLC acquired a new stake in shares of Medtronic during the first quarter worth about $207,000. Advisor OS LLC lifted its holdings in shares of Medtronic by 26.4% during the first quarter. Advisor OS LLC now owns 14,912 shares of the medical technology company's stock worth $1,340,000 after purchasing an additional 3,112 shares during the period. Machina Capital S.A.S. increased its holdings in Medtronic by 58.2% in the 1st quarter. Machina Capital S.A.S. now owns 30,392 shares of the medical technology company's stock worth $2,731,000 after buying an additional 11,185 shares during the period. Finally, Pinnacle Associates Ltd. raised its position in Medtronic by 0.7% during the 1st quarter. Pinnacle Associates Ltd. now owns 121,244 shares of the medical technology company's stock worth $10,895,000 after buying an additional 815 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on MDT. Leerink Partnrs upgraded shares of Medtronic to a "strong-buy" rating in a research note on Monday, June 16th. William Blair raised Medtronic to a "hold" rating in a report on Friday, July 11th. Evercore ISI raised their target price on Medtronic from $103.00 to $106.00 and gave the stock an "outperform" rating in a report on Tuesday, July 8th. Wolfe Research raised Medtronic from an "underperform" rating to a "peer perform" rating in a report on Monday, June 30th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Medtronic in a research note on Friday, June 6th. Eleven equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $98.19.

Medtronic Trading Up 0.6%

Shares of NYSE MDT traded up $0.59 during trading on Friday, hitting $92.91. 5,264,531 shares of the company were exchanged, compared to its average volume of 7,082,213. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.42 and a current ratio of 1.85. Medtronic PLC has a 12-month low of $78.32 and a 12-month high of $96.25. The company has a fifty day moving average price of $87.04 and a 200-day moving average price of $87.53. The firm has a market capitalization of $119.16 billion, a PE ratio of 25.66, a P/E/G ratio of 2.40 and a beta of 0.80.

Medtronic (NYSE:MDT - Get Free Report) last posted its quarterly earnings results on Wednesday, May 21st. The medical technology company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.58 by $0.04. The business had revenue of $8.93 billion during the quarter, compared to analysts' expectations of $8.81 billion. Medtronic had a net margin of 13.90% and a return on equity of 14.54%. The business's revenue for the quarter was up 3.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.46 EPS. As a group, equities research analysts expect that Medtronic PLC will post 5.46 EPS for the current year.

Medtronic Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, July 11th. Stockholders of record on Friday, June 27th were issued a dividend of $0.71 per share. The ex-dividend date of this dividend was Friday, June 27th. This is a boost from Medtronic's previous quarterly dividend of $0.70. This represents a $2.84 dividend on an annualized basis and a dividend yield of 3.06%. Medtronic's dividend payout ratio is currently 78.45%.

Medtronic Company Profile

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.